Ligand Pharmaceuticals LGND Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's invested capital?
- Ligand Pharmaceuticals (LGND) reported invested capital of $887.31M in Q1 2026.
- How has Ligand Pharmaceuticals's invested capital changed year-over-year?
- Ligand Pharmaceuticals's invested capital increased by 18.0% year-over-year, from $752.05M to $887.31M.
- What is the long-term trend for Ligand Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's invested capital has grown at a 4.4% compound annual growth rate (CAGR), from $682.39M to $847.64M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).